Allogene疗法(ALLO)

4.915 -0.135 -2.6733%

今开:4.99昨收:5.05
最高:5.05 最低:4.9066
涨停价:0.0跌停价:0.0
总市值:7.10204637E8

Allogene疗法的热门评论

持股变动声明

Allogene疗法(ALLO)2022-08-16 05:48

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-22-000069 Size: 5 KB 网页链接查看全文

当期报告

Allogene疗法(ALLO)2022-08-10 04:12

$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-22-000065 Act: 34 Size: 242 KB 网页链接查看全文

季度财报

Allogene疗法(ALLO)2022-08-10 04:21

$Allogene疗法(ALLO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001737287-22-000067 Act: 34 Size: 6 MB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)2022-08-03 05:48

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-22-000057 Size: 4 KB 网页链接查看全文

其他

Allogene疗法(ALLO)2022-07-21 04:06

$Allogene疗法(ALLO)$ SC TO-I/A [Amend] Tender offer statement by Issuer Accession Number: 0001737287-22-000056 Act: 34 Size: 28 KB 网页链接查看全文

首次持股声明

Allogene疗法(ALLO)2022-07-13 04:42

$Allogene疗法(ALLO)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001737287-22-000052 Size: 2 KB 网页链接查看全文

当期报告

Allogene疗法(ALLO)2022-07-13 04:12

$Allogene疗法(ALLO)$ 8-K Current report, item 5.02 Accession Number: 0001737287-22-000049 Act: 34 Size: 170 KB 网页链接查看全文

其他

Allogene疗法(ALLO)2022-07-13 04:18

$Allogene疗法(ALLO)$ SC TO-I/A [Amend] Tender offer statement by Issuer Accession Number: 0001737287-22-000051 Act: 34 Size: 43 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)2022-07-13 04:51

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-22-000053 Size: 6 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)2022-07-07 04:21

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001662119-22-000002 Size: 4 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39

Allogene疗法的最新评论

持股变动声明

Allogene疗法(ALLO)03-17 05:36

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 05:12

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 04:57

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)03-17 04:51

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接查看全文

当期报告

Allogene疗法(ALLO)03-11 05:06

$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接查看全文

员工持股计划

Allogene疗法(ALLO)03-01 05:36

$Allogene疗法(ALLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001737287-23-000020 Act: 33 Size: 133 KB 网页链接查看全文

年度财报

Allogene疗法(ALLO)03-01 05:27

$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-23-000018 Act: 34 Size: 12 MB 网页链接查看全文

当期报告

Allogene疗法(ALLO)03-01 05:12

$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-23-000017 Act: 34 Size: 267 KB 网页链接查看全文

持股变动声明

Allogene疗法(ALLO)02-15 06:18

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000317 Size: 4 KB 网页链接查看全文

超过5%股东持股披露「修订」

Allogene疗法(ALLO)02-14 05:36

$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035914 Act: 34 Size: 93 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39

Allogene疗法的公告

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000025 Size: 8 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001737287-23-000024 Size: 6 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000492 Size: 5 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000491 Size: 5 KB 网页链接

当期报告

$Allogene疗法(ALLO)$ 8-K Current report, item 7.01 Accession Number: 0001737287-23-000023 Act: 34 Size: 165 KB 网页链接

员工持股计划

$Allogene疗法(ALLO)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001737287-23-000020 Act: 33 Size: 133 KB 网页链接

年度财报

$Allogene疗法(ALLO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001737287-23-000018 Act: 34 Size: 12 MB 网页链接

当期报告

$Allogene疗法(ALLO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001737287-23-000017 Act: 34 Size: 267 KB 网页链接

持股变动声明

$Allogene疗法(ALLO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001593968-23-000317 Size: 4 KB 网页链接

超过5%股东持股披露「修订」

$Allogene疗法(ALLO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-23-035914 Act: 34 Size: 93 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28